Independent research directory for biotech and pharma procurement — structured capabilities, provenance-backed profiles, and fit-aware shortlists.
Capability index
Jump into fit-scored shortlists for the outsourcing categories buyers evaluate most often.
Daily headlines with sourcing, plus weekly macro analysis for outsourcing directors.
Source: PrimeVigilance News RSS
Operational impact: Ergomed Group Appoints Jovan Willford as CEO to Lead Growth Strategy Jovan Willford, former Cytel CEO and IQVIA executive, assumes Ergomed Group leadership effective November 2, 2026. Willford brings 15+ years in life…
Source: Applied Clinical Trials RSS
Operational impact: EHR-EDC Integration Standards Critical for Real-Time Clinical Trials FDA's real-time clinical trials initiative requires standardized eSource-EDC-EHR digital bridges to eliminate manual data transcription and paper…
Source: PR Newswire pharma category RSS
Operational impact: CU Anschutz Awarded $120M DARPA Contract to Validate Hemorrhage Therapeutics in Clinical Trials University of Colorado Anschutz receives up to $120 million over three years from DARPA to independently verify and…
Source: EMA News and Press RSS
Operational impact: EMA's ACT EU Clinical Trial Advice Pilot Becomes Permanent in January 2027 The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which provides pre-submission regulatory and technical guidance to trial…
Source: PharmaSource RSS
Operational impact: Marvel Biosciences Engages Novotech for Phase 1 First-in-Human Trial of MB-204 in Australia Marvel Biosciences signed a Letter of Intent with Novotech to conduct a Phase 1 SAD/MAD study of MB-204, a novel adenosine A2a…
Featured essay
FDA GCP warning letters to CROs spike in 2026, reshaping compliance prioritiesIn the first quarter of 2026, the FDA issued 27 warning letters to clinical investigators and CROs under its Bioresearch Monitoring (BIMO) program—a volume that signals a sustained enforcement pivot toward trial oversight infrastructure. FDA Warning Letters by the Numbers…
Read full essayFor buyers
Describe your program brief and receive a fit-scored shortlist of CRO partners — ranked on capabilities, geography, and provenance-backed profile data, not paid placement.
Start RFQ briefFor vendors
Verify your corporate email to add your logo and backlink, then complete domain verification for full profile admin, review responses, and buyer-facing visibility on cro.directory. Paid visibility packages add RFQ priority, featured placement, or sponsored side-rail inventory.
We use essential cookies to run the site and Cloudflare Web Analytics (privacy-first, no advertising cookies) for traffic and performance. With your permission we also load Google Analytics 4. We never sell your information, and we do not use it for advertising or ad personalization. You can change the GA4 choice anytime under Cookie preferences.